A recent study showed that blood SCFA levels are directly linked to health maintenance during MS and metabolic diseases (57, 58); therefore, we examined the association between serum SCFA levels and underlying MS-linked intestinal inflammatory activity using Lcn-2 as a readout. This evidence concerns the gene LCN2 and metabolic disease.